
CSL Investor Relations Material
Latest events

H1 2025
CSL
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from CSL Limited
Access all reports
Segment Data
Access more data
Revenue by
Business area
CSL Behring
Seqirus
Expenses by
Financials
CSL Limited, a biopharmaceutical company, researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, Europe, the United States, and internationally. The company operates through two segments, CSL Behring and Seqirus.
Key slides for CSL Limited


H1 2025
CSL Limited


H1 2025
CSL Limited
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
CSL
Country
🇦🇺 Australia